Term ends no later than Nov 29, 2031 · Medium confidence
20-year base term ends Nov 29, 2031
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Nov 29, 2011
Nov 29, 2031
Jun 23, 2015
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 29, 2011, when application 13/306,781, the earliest non-provisional in its chain, was filed (this one was filed Jul 8, 2014) | Nov 29, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Nov 29, 2031 | Medium confidence |
This family
| US 8,853,377 | In force Nov 2031 | Nov 2031 |
| US 9,061,021 | this patent no later than Nov 2031 | no later than Nov 2031 |
| US 9,956,271 | In force Nov 2031 | Nov 2031 |
| US 11,135,274 | In force Nov 2031 | Nov 2031 |
| Application 17/465,287 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 9, 2014 Reel 33699, frame 668 | Guild, Braydon Charles; Heartlein, Michael; Derosa, Frank | Shire Human Genetic Therapies, Inc. | Assignment of Assignor's Interest |
| Apr 6, 2017 Reel 42177, frame 32 | Shire Human Genetic Therapies, Inc. | Rana Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 20, 2017 Reel 43267, frame 165 | Rana Therapeutics, Inc. | Translate Bio, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 29, 2031. We will not guess the cap.